Report - CENTER FOR DRUG EVALUATION AND RESEARCH...The hazard ratio (HR) of having an attack with inebilizumab treatment compared to placebo was 0.272 [95% CI 0.150 – 0.496] representing

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form